In search of an optimum dose escalation for narrowband UVB phototherapy: Is it time to quit 20% increments?

    loading  Checking for direct PDF access through Ovid



Our aim was to compare 20% with 10% to 5% incremental regimens in narrowband UVB phototherapy.

Study patients

The study included patients with psoriasis (N = 191) with Fitzpatrick skin phototypes II and III.


Occurrence of erythema as well as maximum and cumulative doses were higher with 20% escalations, whereas response rates and time to response did not significantly differ.


The study was limited by its retrospective nature.


A 5% or 10% incremental regimen may have similar therapeutic efficacy.

Related Topics

    loading  Loading Related Articles